Differential effects of eprosartan and losartan at prejunctional angiotensin II receptors

被引:25
作者
Guimaraes, S [1 ]
Pinheiro, H [1 ]
Tavares, P [1 ]
Loio, A [1 ]
Moura, D [1 ]
机构
[1] Inst Pharmacol & Therapeut, Fac Med, P-4200319 Porto, Portugal
关键词
eprosartan; losartan; PB123319; angiotensin II receptors; rat ventricle; canine pulmonary artery;
D O I
10.1007/s002100100396
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
A comparison was made of the influence of losartan and eprosartan on angiotensin II effects at pre- and postjunctional receptors of the canine pulmonary artery and at prejunctional receptors of the rat left ventricle. To study postjunctional contractile responses to angio-tensin II, non-cumulative concentration-response curves were determined, to study prejunctional effects of angiotensin II, the tissues were preincubated with [H-3]noradrenaline and then superfused and electrically stimulated (1 Hz, 2 ms, 50 mA, 5 min). Postjunctionally, both losartan and eprosartan caused a parallel shift of the concentration-response curve of angiotensin II to the right (pK(d) of 8.15 and 8.28, respectively). At the prejunctional level, while eprosartan, in concentrations similar to those which were effective postjunctionally (36-100 nM), antagonized the facilitatory effect on noradrenaline release in both the dog pulmonary artery and the rat ventricle, Iosartan was ineffective in concentrations up to 1 muM. It is concluded that prejunctional receptors for angiotensin II in the canine pulmonary artery and in the rat left ventricle are different from postjunctional receptors of the canine pulmonary artery. It is proposed that the prejunctional receptors of these tissues are atypical AT(1) or "AT(1B)-like" receptors.
引用
收藏
页码:509 / 514
页数:6
相关论文
共 50 条
  • [31] PHARMACOLOGY OF LOSARTAN, AN ANGIOTENSIN-II RECEPTOR ANTAGONIST, IN ANIMAL-MODELS OF HYPERTENSION
    SIEGL, PKS
    KIVLIGHN, SD
    BROTEN, TP
    JOURNAL OF HYPERTENSION, 1995, 13 : S15 - S21
  • [32] Venoconstriction by angiotensin II in the human forearm is inhibited by losartan but not by nicardipine
    Baan, J
    Chang, PC
    Vermeij, P
    Pfaffendorf, M
    van Zwieten, PA
    JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 1998, 31 (01) : 50 - 55
  • [33] BIOCHEMICAL EFFECTS OF LOSARTAN, A NONPEPTIDE ANGIOTENSIN-II RECEPTOR ANTAGONIST, ON THE RENIN-ANGIOTENSIN-ALDOSTERONE SYSTEM IN HYPERTENSIVE PATIENTS
    GOLDBERG, MR
    BRADSTREET, TE
    MCWILLIAMS, EJ
    TANAKA, WK
    LIPERT, S
    BJORNSSON, TD
    WALDMAN, SA
    OSBORNE, B
    PIVADORI, L
    LEWIS, G
    BLUM, R
    HERMAN, T
    ABRAHAM, PA
    HALSTENSON, CN
    LO, MW
    LU, H
    SPECTOR, R
    HYPERTENSION, 1995, 25 (01) : 37 - 46
  • [34] Assessment of once-daily eprosartan, an angiotensin II antagonist, in patients with systemic hypertension
    Gradman, AH
    Gray, J
    Maggiacomo, F
    Punzi, H
    White, WB
    CLINICAL THERAPEUTICS, 1999, 21 (03) : 442 - 453
  • [35] Effects of angiotensin II receptor antagonist, Losartan on the apoptosis, proliferation and migration of the human pancreatic stellate cells
    Liu, Wen-Bin
    Wang, Xing-Peng
    Wu, Kai
    Zhang, Ru-Ling
    WORLD JOURNAL OF GASTROENTEROLOGY, 2005, 11 (41) : 6489 - 6494
  • [36] EFFECTS OF LOSARTAN, AN ANGIOTENSIN-II ANTAGONIST, ON THE DEVELOPMENT OF CARDIAC-HYPERTROPHY DUE TO VOLUME OVERLOAD
    ISHIYE, M
    UMEMURA, K
    UEMATSU, T
    NAKASHIMA, M
    BIOLOGICAL & PHARMACEUTICAL BULLETIN, 1995, 18 (05) : 700 - 704
  • [37] EFFECTS OF LOSARTAN ON BLOOD-PRESSURE, PLASMA-RENIN ACTIVITY, AND ANGIOTENSIN-II IN VOLUNTEERS
    GOLDBERG, MR
    TANAKA, W
    BARCHOWSKY, A
    BRADSTREET, TE
    MCCREA, J
    LO, MW
    MCWILLIAMS, EJ
    BJORNSSON, TD
    HYPERTENSION, 1993, 21 (05) : 704 - 713
  • [38] Different types of antagonism by losartan and irbesartan on the effects of angiotensin II and its degradation products in rabbit arteries
    Li, Q
    Pfaffendorf, M
    van Zwieten, PA
    FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2001, 15 (02) : 143 - 150
  • [39] Receptor subtypes mediating spinal cardiovascular effects of angiotensin II in rat using losartan and PD 123319
    Park, PDS
    Henry, JL
    EUROPEAN JOURNAL OF PHARMACOLOGY, 1997, 326 (2-3) : 139 - 145
  • [40] The Effects of the Angiotensin II Receptor Antagonist Losartan on Appetitive Versus Aversive Learning: A Randomized Controlled Trial
    Pulcu, Erdem
    Shkreli, Lorika
    Hoist, Carolina Guzman
    Woud, Marcella L.
    Craske, Michelle G.
    Browning, Michael
    Reinecke, Andrea
    BIOLOGICAL PSYCHIATRY, 2019, 86 (05) : 397 - 404